Soltis Investment Advisors LLC Makes New Investment in Zoetis Inc. (NYSE:ZTS)

Soltis Investment Advisors LLC bought a new position in shares of Zoetis Inc. (NYSE:ZTS - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 2,106 shares of the company's stock, valued at approximately $343,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the stock. Darwin Wealth Management LLC acquired a new position in shares of Zoetis during the third quarter valued at about $31,000. First Personal Financial Services bought a new position in shares of Zoetis during the 3rd quarter worth about $33,000. Capital Performance Advisors LLP acquired a new position in Zoetis during the 3rd quarter worth approximately $33,000. Dunhill Financial LLC boosted its holdings in Zoetis by 80.6% in the third quarter. Dunhill Financial LLC now owns 168 shares of the company's stock worth $33,000 after acquiring an additional 75 shares in the last quarter. Finally, Fortitude Family Office LLC boosted its holdings in Zoetis by 1,387.5% in the third quarter. Fortitude Family Office LLC now owns 238 shares of the company's stock worth $46,000 after acquiring an additional 222 shares in the last quarter. Institutional investors own 92.80% of the company's stock.

Wall Street Analyst Weigh In

Several research analysts have issued reports on ZTS shares. Piper Sandler cut their price target on Zoetis from $210.00 to $200.00 and set an "overweight" rating on the stock in a report on Monday, February 10th. Stifel Nicolaus dropped their target price on Zoetis from $210.00 to $180.00 and set a "buy" rating on the stock in a report on Tuesday, January 7th. Leerink Partnrs upgraded Zoetis to a "strong-buy" rating in a report on Monday, December 2nd. Leerink Partners began coverage on Zoetis in a report on Monday, December 2nd. They issued an "outperform" rating and a $215.00 target price on the stock. Finally, UBS Group began coverage on Zoetis in a report on Monday, December 9th. They issued a "neutral" rating and a $196.00 target price on the stock. One equities research analyst has rated the stock with a hold rating, ten have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Buy" and a consensus target price of $214.90.

Remove Ads

Insiders Place Their Bets

In other news, EVP Roxanne Lagano sold 326 shares of Zoetis stock in a transaction on Tuesday, February 11th. The stock was sold at an average price of $171.18, for a total value of $55,804.68. Following the completion of the transaction, the executive vice president now directly owns 16,107 shares in the company, valued at approximately $2,757,196.26. The trade was a 1.98 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 0.16% of the company's stock.

Zoetis Stock Performance

Shares of ZTS traded down $7.40 on Friday, reaching $157.54. 7,656,606 shares of the company's stock traded hands, compared to its average volume of 2,578,743. The company has a current ratio of 3.69, a quick ratio of 2.27 and a debt-to-equity ratio of 1.26. The stock has a market cap of $71.07 billion, a PE ratio of 29.61, a PEG ratio of 2.77 and a beta of 0.90. The stock's 50 day simple moving average is $168.51 and its two-hundred day simple moving average is $178.81. Zoetis Inc. has a 52-week low of $144.80 and a 52-week high of $200.53.

Zoetis (NYSE:ZTS - Get Free Report) last released its earnings results on Thursday, February 13th. The company reported $1.40 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.37 by $0.03. Zoetis had a return on equity of 51.98% and a net margin of 26.55%. The business had revenue of $2.32 billion during the quarter, compared to the consensus estimate of $2.30 billion. On average, analysts forecast that Zoetis Inc. will post 5.9 earnings per share for the current fiscal year.

Zoetis Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 3rd. Shareholders of record on Monday, April 21st will be given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 1.27%. The ex-dividend date of this dividend is Monday, April 21st. Zoetis's dividend payout ratio is currently 36.56%.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.